Literatur
- 1
Boers M, Verhoeven A C, Markusse H M. et al .
Randomised comparison of
combined step-down prednisolone, methotrexate and sulphasalazine
with sulphasalazine alone in early rheumatoid arthritis.
Lancet.
1997;
350
309-318
- 2
Breedveld F C.
Is
there a place for leflunomide in the treatment of rheumatoid arthritis?.
Lancet.
2001;
358
1198-1200
- 3
Calcuneri M, Pay S, Caliskaner Z. et al .
Combination therapy versus monotherapy
for the treatment of patients with rheumatoid arthritis.
Clin
Exp Rheumatol.
1999;
17
699-704
- 4
Cush J J, Tugwell P, Weinblatt M, Yocum D.
US consensus guidelines for
the use of cyclosporin A in rheumatoid arthritis.
J Rheumatol.
1999;
26
1176-1186
- 5
Kremer M, Genovese M C, Cannon G W. et al .
Concomitant leflunomide therapy
in patients with active rheumatoid arthritis despite stable doses
of methotrexate. A randomized, double-blind, placebo-controlled
trial.
Ann Intern Med .
2002;
137
726-733
- 6
Kremer J, Genovese M, Caldwell R. et al .
Combination of leflunomide and methotrexate
in patients with active rheumatoid arthritis failing MTX monotherapy:
An open-label extension study.
Arthritis Rheum.
2001;
44
(Suppl)
A549
- 7
Kremer J M.
Rational
use of new and existing disease-modifying agents in rheumatoid arthritis.
Ann
Intern Med.
2001;
134
695-706
- 8
Lerin-Lozano C, Schnabel A, Erbsloh-Moller B, Gross W L.
Is methotrexate
plus cyclosporine A a useful salvage therapy for rheumatoid arthritis
patients unresponsive to other types of methotrexate combination
treatment?.
Clin Exp Rheumatol.
2002;
20
737 (Letter)
- 9
Möttönen T, Hannonen P, Leirisalo-Repo M. et al. FIN-RACo trial group .
Comparison
of combination therapy with single-drug therapy in early rheumatoid
arthritis: a randomised trial.
Lancet.
1999;
353
1568-1573
- 10
Möttönen T, Hannonen P, Korpela M. et al .
Delay to institution of
therapy and induction of remission using single-drug or combination-disease-modifying
antirheumatic drug therapy in early rheumatoid arthritis.
Arthritis
Rheum.
2002;
46
894-898
- 11
O’Dell J R, Haire C E, Erikson N. et al .
Treatment of rheumatoid
arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine,
or a combination of all three medications.
N Engl J Med.
1996;
334
1287-1291
- 12
OŽDell R, Leff R, Paulsen G. et al .
Treatment of rheumatoid arthritis with
methotrexate and hydroxychloroquine, methotrexate and sulfasalazine,
or a combination of the three medications.
Arthritis Rheum.
2002;
46
1164-1170
- 13
Reinhold-Keller E, Gross W L.
Leflunomid zur
Behandlung der Rheumatoiden Arthritis.
Dt Ärztebl.
2001;
98
1881-1887
- 14
Schmidt W A.
Value
of sonography in diagnosis of rheumatoid arthritis.
Lancet.
2001;
357
1056-1057
- 15
Schnabel A, Gross W L.
Low-dose methotrexate
in rheumatic diseases - Efficacy, side effects, and risk
factors for side effects.
Semin Arthritis Rheum.
1994;
23
310-327
- 16
Tugwell P, Pincus T, Yocum D. et al .
Combination therapy with cyclosporine and
methotrexate in severe rheumatoid arthritis.
N Engl J Med.
1995;
333
137-141
- 17
Van Everdingen A A, Jacobs W G, Siewertsz
van Reesema D R. et al .
Low-dose
prednisone therapy for patients with early active rheumatoid arthritis:
Clinical efficacy, disease-modifying properties, and side effects.
Ann
Intern Med.
2002;
136
1-12
- 18
Zeidler H, Rau R, Steinfeld P.
Efficacy
and safety of low dose prednisolone in early rheumatoid arthritis
(RA).
Arthritis Rheum.
1999;
42
S271
(Suppl)
- 19
Zink A, Listing J, Ziemer S, Zeidler H.
Practice variation in the
treatment of rheumatoid arthritis among German rheumatologists.
J Rheumatol.
2001;
28
2201-2208
1 Der Teil „Zytokinantagonisten” erscheint
im nächsten Heft (Nr. 5)
Priv.-Doz. Dr. Armin Schnabel
Sana Rheumazentrum Baden-Württemberg
König-Karl-Straße
5
75323 Bad Wildbad
Phone: 07081/172222
Fax: 07081/172250
Email: a.schnabel@sana-wildbad.de
